Diabetic Macular Edema (DME) Overview
Learn About Diabetic Macular Edema (DME)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Of Utah Adult Services
Amir Kashani is a Gastroenterologist in Salt Lake City, Utah. Dr. Kashani and is rated as an Advanced provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Gas Bloat Syndrome, Colitis, Crohn's Disease, Vitrectomy, and Endoscopy. Dr. Kashani is currently accepting new patients.
Nicolas Cordoba is a Pediatrics specialist and an Internal Medicine provider in Salt Lake City, Utah. Dr. Cordoba has been practicing medicine for over 14 years and is rated as an Experienced provider by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Type 2 Diabetes (T2D), Diabetic Macular Edema (DME), Hypertensive Heart Disease, and Peptic Ulcer. Dr. Cordoba is currently accepting new patients.
University Of Utah Adult Services
Elizabeth Fairless is an Ophthalmologist in Salt Lake City, Utah. Dr. Fairless and is rated as an Experienced provider by MediFind in the treatment of Diabetic Macular Edema (DME). Her top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, and Diabetic Macular Edema (DME). Dr. Fairless is currently accepting new patients.
Summary: This study will assess the safety and tolerability of RO7497372 in participants with DME. The study consists of 2 parts. Part 1 will test multiple-ascending doses of RO7497372 after unilateral intravitreal (IVT) administration in participants with DME. The main purpose of Part 1 is to provide data for RO7497372 safety and tolerability, as well as to characterize the ocular and systemic pharmacokin...
Summary: The purpose of this clinical study is to explore the efficacy of dapagliflozin as an adjunct to intravitreal anti-vascular endothelial growth factor (anti-VEGF) for enhanced reduction of retinal thickness and vision improvement in patients with diabetic macular edema. The main question the study aims to answer is: Does dapagliflozin reduce the thickness of the macula when combined with the standar...